Patent details

Basic Information

Publication number:

EP2545080

PCT Application Number:

US2011028233

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117542316

PCT Publication Number:

WO2011113027

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NPP1 FUSION PROTEINS

French Title of Invention:

PROTÉINES DE FUSION NPP1

German Title of Invention:

NPP1-FUSIONSPROTEINE

SPC Number:

Dates

Filing date:

11/03/2011

Grant date:

10/05/2017

EP Publication Date:

16/01/2013

PCT Publication Date:

15/09/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/05/2017

EP B1 Publication Date:

10/05/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/03/2018

Expiration date:

11/03/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/05/2017

 

 

Name:

Alexion Pharmaceuticals, Inc.

Address:

100 College Street, New Haven, CT 06510, United States (US)

Inventor

1

Name:

QUINN, Anthony

Address:

United States (US)

2

Name:

XIA, Zhinan

Address:

United States (US)

3

Name:

HARVEY, Alex J.

Address:

United States (US)

Priority

Priority Number:

340066 P

Priority Date:

12/03/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/46; A61P 9/00; C07K 19/00; C12N 9/22; C12N 15/55; C12N 15/62; C12N 15/85;

Publication

European Patent Bulletin

Issue number:

201719

Publication date:

10/05/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/07/2018	Outgoing Correspondence	1